Portfolio of Marijuana (Cannabis) Pharma Stocks Traded on the NYSE and NASDAQ

Here is a table of 7 cannabis stocks that are developing cannabis compound medicines.

7 Cannabis Pharma Stocks
Stock Returns & Price Chart	Symbol	Recent Prices & Annualized Return
Abbvie	ABBV
Arena Pharmaceuticals	ARNA
Cara Therapeutics	CARA
Corbus Pharmaceuticals Holdings	CRBP
GW Pharmaceuticals	GWPH
INSYS Therapeutics	INSY
Zynerba Pharmaceuticals	ZYNE
Price data from Quandl as of most recent close.

To inspect the performance of the Cannabis Pharma Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Quandl.

All 7 stocks are included in the portfolio computations. The current value of the portfolio assumes that $1,428.57 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends.

The current value of a $10,000 investment is $9,401. The percent return is -5.99%. The annualized return is -2.71%.

Return Summary for Cannabis Pharma Stocks
Start Date	Sep-29-2017
Start Investment	$10,000.00
End Date	Dec-06-2019
Current Value of Investment	$9,401.33
Total Return	-5.99%
Annualized Return	-2.71%
Min Date	Dec-31-2018
Min Price	$8,220.34
Max Date	Jun-28-2019
Max Price	$12,951.80
# Values	28
Number Returns	378
Number Profitable Returns	217
Percent Profitable Returns	57.41%
Number Unprofitable Returns	161
Percent Unprofitable Returns	42.59%
Profitable to Unprofitable Returns Ratio	1.35